Dankó, T.; Petővári, G.; Raffay, R.; Sztankovics, D.; Moldvai, D.; Vetlényi, E.; Krencz, I.; Rókusz, A.; Sipos, K.; Visnovitz, T.;
et al. Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting. Int. J. Mol. Sci. 2022, 23, 7444.
https://doi.org/10.3390/ijms23137444
AMA Style
Dankó T, Petővári G, Raffay R, Sztankovics D, Moldvai D, Vetlényi E, Krencz I, Rókusz A, Sipos K, Visnovitz T,
et al. Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting. International Journal of Molecular Sciences. 2022; 23(13):7444.
https://doi.org/10.3390/ijms23137444
Chicago/Turabian Style
Dankó, Titanilla, Gábor Petővári, Regina Raffay, Dániel Sztankovics, Dorottya Moldvai, Enikő Vetlényi, Ildikó Krencz, András Rókusz, Krisztina Sipos, Tamás Visnovitz,
and et al. 2022. "Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting" International Journal of Molecular Sciences 23, no. 13: 7444.
https://doi.org/10.3390/ijms23137444
APA Style
Dankó, T., Petővári, G., Raffay, R., Sztankovics, D., Moldvai, D., Vetlényi, E., Krencz, I., Rókusz, A., Sipos, K., Visnovitz, T., Pápay, J., & Sebestyén, A.
(2022). Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting. International Journal of Molecular Sciences, 23(13), 7444.
https://doi.org/10.3390/ijms23137444